The overall aim of research in my laboratory is to understand how cytokines and other disease-associated factors regulate key cellular processes during atherosclerosis with the goal of identifying new therapeutic/preventative targets/avenues. Research uses a combination of in vitro and in vivo model systems coupled with molecular, biochemical, immunological and pharmacological approaches. More recently, the mechanisms underlying the protective actions of nutraceuticals in atherosclerosis and key cellular processes associated with this disease are being investigated. Previous and current research has been funded by grants from the British Heart Foundation, Wellcome Trust, BBSRC, MRC, EU and Industry.

- Published over 180 research articles
- Regular invited talks, including Keynote/Plenary, at numerous international conferences on Atherosclerosis, Cardiovascular Disease and Drug Discovery
- Scientific Advisory Board of the International Academy of Cardiology
- Organising Committee Member for 13 International Conferences, including 16th Euro Fed Lipid Congress and Expo, World Congress on Heart Disease and Annual Conference on Atherosclerosis & Clinical Cardiology
- Expert/Panel member for EU (Horizon 2020) and the IRCSET Postdoctoral Fellowship Scheme Ireland
- Member of the Editorial Board of 10 International Journals
- Reviewed grant applications for over 20 funding organisations, including 14 outside the UK
- Ad hoc reviewer of over 36 journals in Molecular Biology and Cardiovascular Disease
- Previous BBSRC Pool of Expert and member of the MRC Advisory Board
- External Examiner for BSc in Biochemistry at Kings College London, BSc in Biomedical Sciences at University of Reading, Biological Sciences at University of Huddersfield and taught MSc programmes at Sheffield Hallam University
- Lectures in Molecular Biology and Molecular Basis of Disease
- Track chair for over 20 International Conferences, including World Congress on Heart Disease, International Conference on Drug Discovery & Therapy and International Conference on Advances in Pharmaceutical and Health Science
- External examiner for 23 PhD/MSc students, including international (Ireland, India and Malaysia)